Source Paper
Source Paper
Stephen C. Benoit, Christopher J. Kemp, Carol F. Elias, William Abplanalp, James P. Herman et al.
Journal of Clinical Investigation • 2009
Insulin signaling can be modulated by several isoforms of PKC in peripheral tissues. Here, we assessed whether one specific isoform, PKC-theta, was expressed in critical CNS regions that regulate energy balance and whether it mediated the deleterious effects of diets high in fat, specifically palmitic acid, on hypothalamic insulin activity in rats and mice. Using a combination of in situ hybridization and immunohistochemistry, we found that PKC-theta was expressed in discrete neuronal populations of the arcuate nucleus, specifically the neuropeptide Y/agouti-related protein neurons and the dorsal medial nucleus in the hypothalamus. CNS exposure to palmitic acid via direct infusion or by oral gavage increased the localization of PKC-theta to cell membranes in the hypothalamus, which was associated with impaired hypothalamic insulin and leptin signaling. This finding was specific for palmitic acid, as the monounsaturated fatty acid, oleic acid, neither increased membrane localization of PKC-theta nor induced insulin resistance. Finally, arcuate-specific knockdown of PKC-theta attenuated diet-induced obesity and improved insulin signaling. These results suggest that many of the deleterious effects of high-fat diets, specifically those enriched with palmitic acid, are CNS mediated via PKC-theta activation, resulting in reduced insulin activity.
Objective: Assess whether PKC-θ mediates the deleterious effects of palmitic acid on hypothalamic insulin signaling by examining PKC-θ membrane localization in response to CNS palmitic acid exposure
This is a Palmitic Acid CNS Infusion protocol using rodents (rats and mice) as the model organism. The procedure involves 7 procedural steps, 3 equipment items, 2 materials. Extracted from a 2009 paper published in Journal of Clinical Investigation.
Model and subjects
rodents (rats and mice) • Not specified in provided text • unknown • Not specified in provided text • Not specified in provided text
Study window
Estimated timing pending
Core workflow
Identify PKC-θ expression in hypothalamic regions • Confirm PKC-θ protein localization • Administer palmitic acid via direct CNS infusion
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Use in situ hybridization to detect PKC-θ mRNA expression in the arcuate nucleus and dorsal medial nucleus of the hypothalamus
Note: Focus on neuropeptide Y/agouti-related protein neurons and dorsal medial nucleus as target regions
“Using a combination of in situ hybridization and immunohistochemistry, we found that PKC-θ was expressed in discrete neuronal populations of the arcuate nucleus”
Use immunohistochemistry to visualize PKC-θ protein distribution in the identified hypothalamic regions
Note: Immunohistochemistry complements in situ hybridization findings
“Using a combination of in situ hybridization and immunohistochemistry, we found that PKC-θ was expressed in discrete neuronal populations”
Deliver palmitic acid directly into the central nervous system via infusion to assess effects on PKC-θ subcellular localization
Note: Direct infusion allows for localized hypothalamic exposure to palmitic acid
“CNS exposure to palmitic acid via direct infusion or by oral gavage increased the localization of PKC-θ to cell membranes in the hypothalamus”
Use immunohistochemistry to determine if palmitic acid infusion increases PKC-θ translocation to cell membranes in hypothalamic tissue
Note: Membrane localization of PKC-θ indicates activation of the kinase
“CNS exposure to palmitic acid via direct infusion or by oral gavage increased the localization of PKC-θ to cell membranes in the hypothalamus”
Assess insulin and leptin signaling pathways in the hypothalamus following palmitic acid-induced PKC-θ membrane localization
Note: Impaired signaling is expected to correlate with PKC-θ membrane localization
“which was associated with impaired hypothalamic insulin and leptin signaling”
Administer oleic acid (monounsaturated fatty acid) via the same route and assess whether it produces similar effects on PKC-θ localization and insulin signaling
Note: Oleic acid serves as a negative control to demonstrate specificity of palmitic acid effects
“This finding was specific for palmitic acid, as the monounsaturated fatty acid, oleic acid, neither increased membrane localization of PKC-θ nor induced insulin resistance”
Use molecular techniques to selectively reduce PKC-θ expression in the arcuate nucleus and assess effects on diet-induced obesity and insulin signaling
Note: Knockdown approach tests whether PKC-θ is necessary for palmitic acid-induced insulin resistance
“arcuate-specific knockdown of PKC-θ attenuated diet-induced obesity and improved insulin signaling”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
Assess whether PKC-θ mediates the deleterious effects of palmitic acid on hypothalamic insulin signaling by examining PKC-θ membrane localization in response to CNS palmitic acid exposure
Objective
Assess whether PKC-θ mediates the deleterious effects of palmitic acid on hypothalamic insulin signaling by examining PKC-θ membrane localization in response to CNS palmitic acid exposure
Subjects
From paperrodents (rats and mice) • Not specified in provided text • unknown • Not specified in provided text • Not specified in provided text
Cohort notes
From paperStudy used both rats and mice as experimental models
Identify PKC-θ expression in hypothalamic regions (Not specified in provided text)
Confirm PKC-θ protein localization (Not specified in provided text)
Administer palmitic acid via direct CNS infusion (Not specified in provided text)
Assess PKC-θ membrane localization after palmitic acid exposure (Not specified in provided text)
PKC-θ mRNA expression in arcuate nucleus and dorsal medial nucleus
From paperNot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
PKC-θ protein localization (cytoplasmic vs. membrane)
From paperNot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
PKC-θ membrane translocation in response to palmitic acid
From paperNot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Hypothalamic insulin signaling pathway activity
From paperNot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
PKC-θ mRNA expression in arcuate nucleus and dorsal medial nucleus
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
PKC-θ protein localization (cytoplasmic vs. membrane)
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
PKC-θ membrane translocation in response to palmitic acid
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Hypothalamic insulin signaling pathway activity
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
Not specified in provided text
Scoring or quantification
Quantify the primary readouts for this experiment: PKC-θ mRNA expression in arcuate nucleus and dorsal medial nucleus; PKC-θ protein localization (cytoplasmic vs. membrane); PKC-θ membrane translocation in response to palmitic acid; Hypothalamic insulin signaling pathway activity.
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for PKC-θ mRNA expression in arcuate nucleus and dorsal medial nucleus, PKC-θ protein localization (cytoplasmic vs. membrane), PKC-θ membrane translocation in response to palmitic acid, Hypothalamic insulin signaling pathway activity.
Source links and direct wording from the methods section for validation and deeper review.
Citation
Stephen C. Benoit et al. (2009). Palmitic acid mediates hypothalamic insulin resistance by altering PKC-θ subcellular localization in rodents. Journal of Clinical Investigation
“”
“”
“”
“”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Gather these items before starting the experiment. Check off items as you prepare.
Not specified in provided text • Not specified in provided text • Not specified in provided text • Not specified in provided text
Not specified in provided text • Not specified in provided text • Not specified in provided text • Not specified in provided text
Not specified in provided text • Not specified in provided text • Not specified in provided text • Not specified in provided text
Not specified in provided text • Not specified in provided text • Not specified in provided text • Not specified in provided text
Not specified in provided text • Not specified in provided text • Not specified in provided text • Not specified in provided text
Not specified in provided text • Not specified in provided text
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Feb 28, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
7
Evidence Quotes
12
Protocol Items
5
Linked Products
0
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Feb 28, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
7
Evidence
12
Specific Products
0/0
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Feb 28, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.
What still needs work